These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 24458148

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.
    Mata D, Linn DM, Linn CL.
    Neuropharmacology; 2015 Dec; 99():337-46. PubMed ID: 26239818
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model.
    Zhou X, Cheng Y, Zhang R, Li G, Yang B, Zhang S, Wu J.
    Sci Rep; 2017 May 11; 7(1):1734. PubMed ID: 28496108
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss.
    Blanco R, Martínez-Navarrete G, Valiente-Soriano FJ, Avilés-Trigueros M, Pérez-Rico C, Serrano-Puebla A, Boya P, Fernández E, Vidal-Sanz M, de la Villa P.
    Exp Eye Res; 2017 Nov 11; 164():37-45. PubMed ID: 28827028
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC, Waxman SG.
    Invest Ophthalmol Vis Sci; 2005 Nov 11; 46(11):4164-9. PubMed ID: 16249495
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action.
    Swartz MM, Linn DM, Linn CL.
    Neuropharmacology; 2013 Oct 11; 73():111-21. PubMed ID: 23727438
    [Abstract] [Full Text] [Related]

  • 15. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration.
    Salinas-Navarro M, Alarcón-Martínez L, Valiente-Soriano FJ, Jiménez-López M, Mayor-Torroglosa S, Avilés-Trigueros M, Villegas-Pérez MP, Vidal-Sanz M.
    Exp Eye Res; 2010 Jan 11; 90(1):168-83. PubMed ID: 19835874
    [Abstract] [Full Text] [Related]

  • 16. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
    Guo L, Salt TE, Maass A, Luong V, Moss SE, Fitzke FW, Cordeiro MF.
    Invest Ophthalmol Vis Sci; 2006 Feb 11; 47(2):626-33. PubMed ID: 16431960
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C, Moore MJ, Zhang X, Klassen H, Langer R, Young M.
    Mol Vis; 2007 Sep 24; 13():1783-92. PubMed ID: 17960131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
    Liu H, Anders F, Thanos S, Mann C, Liu A, Grus FH, Pfeiffer N, Prokosch-Willing V.
    Invest Ophthalmol Vis Sci; 2017 Oct 01; 58(12):5129-5141. PubMed ID: 28986598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.